<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36793333</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-2360</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in pediatrics</Title><ISOAbbreviation>Front Pediatr</ISOAbbreviation></Journal><ArticleTitle>Long COVID in children and adolescents: COVID-19 follow-up results in third-level pediatric hospital.</ArticleTitle><Pagination><StartPage>1016394</StartPage><MedlinePgn>1016394</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1016394</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2023.1016394</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">In children, the manifestations of coronavirus disease 2019 (COVID-19) in the acute phase are considered mild compared with those in adults; however, some children experience a severe disease that requires hospitalization. This study was designed to present the operation and follow-up results of the Post-COVID-19 Detection and Monitoring Sequels Clinic of Hospital Infantil de Mexico Federico G&#xf3;mez in managing children with a history of SARS-CoV-2 infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This was a prospective study conducted from July 2020 to December 2021, which included 215 children aged 0-18 years who tested positive for SARS-CoV-2 on polymerase chain reaction and/or immunoglobulin G test. The follow-up was conducted in the pulmonology medical consultation; ambulatory and hospitalized patients were assessed at 2, 4, 6, and 12 months.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The median age of the patients was 9.02 years, and neurological, endocrinological, pulmonary, oncological, and cardiological comorbidities were the most commonly observed among the patients. Moreover, 32.6% of the children had persistent symptoms at 2 months, 9.3% at 4 months, and 2.3% at 6 months, including dyspnea, dry cough, fatigue, and runny nose; the main acute complications were severe pneumonia, coagulopathy, nosocomial infections, acute renal injury, cardiac dysfunction, and pulmonary fibrosis. The more representative sequelae were alopecia, radiculopathy, perniosis, psoriasis, anxiety, and depression.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">This study showed that children experience persistent symptoms, such as dyspnea, dry cough, fatigue, and runny nose, although to a lesser extent than adults, with significant clinical improvement 6 months after the acute infection. These results indicate the importance of monitoring children with COVID-19 through face-to-face consultations or telemedicine, with the objective of offering multidisciplinary and individualized care to preserve the health and quality of life of these children.</AbstractText><CopyrightInformation>&#xa9; 2023 Jamaica Balderas, Navarro Fern&#xe1;ndez, Dragustinovis Garza, Orellana Jerves, Sol&#xed;s Figueroa, Koretzky, M&#xe1;rquez Gonz&#xe1;lez, Kl&#xfc;nder Kl&#xfc;nder, Espinosa, Nieto Zerme&#xf1;o, Villa Guill&#xe9;n, Rosales Uribe and Olivar L&#xf3;pez.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jamaica Balderas</LastName><ForeName>Lourdes Mar&#xed;a Del Carmen</ForeName><Initials>LMDC</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Hospital Infantil de Mexico Federico Gomez Instituto Nacional de Salud, Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarro Fern&#xe1;ndez</LastName><ForeName>Amairani</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Hospital Infantil de Mexico Federico Gomez Instituto Nacional de Salud, Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dragustinovis Garza</LastName><ForeName>Susana Azeneth</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Hospital Infantil de Mexico Federico Gomez Instituto Nacional de Salud, Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orellana Jerves</LastName><ForeName>Mar&#xed;a Isabel</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Hospital Infantil de Mexico Federico Gomez Instituto Nacional de Salud, Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sol&#xed;s Figueroa</LastName><ForeName>Walter Ernesto</ForeName><Initials>WE</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Hospital Infantil de Mexico Federico Gomez Instituto Nacional de Salud, Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koretzky</LastName><ForeName>Solange Gabriela</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, Hospital Infantil de Mexico Federico Gomez Instituto Nacional de Salud, Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe1;rquez Gonz&#xe1;lez</LastName><ForeName>Horacio</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, Hospital Infantil de Mexico Federico Gomez Instituto Nacional de Salud, Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kl&#xfc;nder Kl&#xfc;nder</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, Hospital Infantil de Mexico Federico Gomez Instituto Nacional de Salud, Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espinosa</LastName><ForeName>Juan Gardu&#xf1;o</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, Hospital Infantil de Mexico Federico Gomez Instituto Nacional de Salud, Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieto Zerme&#xf1;o</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>General Direction, Hospital Infantil de Mexico Federico Gomez Instituto Nacional de Salud, Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villa Guill&#xe9;n</LastName><ForeName>M&#xf3;nica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>General Direction, Hospital Infantil de Mexico Federico Gomez Instituto Nacional de Salud, Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosales Uribe</LastName><ForeName>R&#xf3;mulo Erick</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>General Direction, Hospital Infantil de Mexico Federico Gomez Instituto Nacional de Salud, Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olivar L&#xf3;pez</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Hospital Infantil de Mexico Federico Gomez Instituto Nacional de Salud, Mexico, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pediatr</MedlineTA><NlmUniqueID>101615492</NlmUniqueID><ISSNLinking>2296-2360</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mexico</Keyword><Keyword MajorTopicYN="N">dyspnea</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>16</Day><Hour>2</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36793333</ArticleId><ArticleId IdType="pmc">PMC9922986</ArticleId><ArticleId IdType="doi">10.3389/fped.2023.1016394</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fainardi V, Meoli A, Chiopris G, Motta M, Skenderaj K, Grandinetti R, et al. Long COVID in children and adolescents. Life. (2022) 12:1&#x2013;13. 10.3390/life12020285</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020285</ArticleId><ArticleId IdType="pmc">PMC8876679</ArticleId><ArticleId IdType="pubmed">35207572</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children &#x2014; a nationwide cohort study. Eur J Pediatr. (2022) 181:1597&#x2013;607. 10.1007/s00431-021-04345-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Luis F, Moncayo G. Informe Integral de COVID-19 en M&#xe9;xico. No. 01-2022. Enero 2022.</Citation></Reference><Reference><Citation>Id LGJ, Paleoudis EG, Bari DL, Nyirenda T, Friedman T, Gupta A, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PloS One. (2020) 12:1&#x2013;14. 10.1371/journal.pone.0243882</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Toro A, Bozzani A, Tavazzi G, Urtis M, Giuliani L, Pizzoccheri R, et al. Long COVID: long-term effects? Eur Hear J. (2021) 23:E1&#x2013;5. 10.1093/eurheartj/suab080</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/suab080</ArticleId><ArticleId IdType="pmc">PMC8503490</ArticleId><ArticleId IdType="pubmed">34650349</ArticleId></ArticleIdList></Reference><Reference><Citation>Brackel CLH, Lap CR, Buddingh EP, van Houten MA, van der Sande LJTM, Langereis EJ, et al. Pediatric long-COVID: an overlooked phenomenon? Pediatr Pulmonol. (2021) 56:2495&#x2013;502. 10.1002/ppul.25521</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25521</ArticleId><ArticleId IdType="pmc">PMC8242715</ArticleId><ArticleId IdType="pubmed">34102037</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID - mechanisms, risk factors, and management. Br Med J. (2021) 374:1&#x2013;18. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Graff K, Smith C, Silveira L, Jung S, Curran-Hays S, Jarjour J, et al. Risk factors for severe COVID-19 in children. Pediatr Infect Dis J. (2021) 40:E137&#x2013;45. 10.1097/INF.0000000000003043</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003043</ArticleId><ArticleId IdType="pubmed">33538539</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, Tleyjeh IM. Unraveling the mystery surrounding post-acute sequelae of COVID-19. Front Immunol. (2021) 12:1&#x2013;16. 10.3389/fimmu.2021.686029</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686029</ArticleId><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z, Yang M, Lai CL. Long COVID-19 syndrome: a comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans. Biomedicines. (2021) 9(8):1&#x2013;19. 10.3390/biomedicines9080966</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080966</ArticleId><ArticleId IdType="pmc">PMC8394513</ArticleId><ArticleId IdType="pubmed">34440170</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V, Gao M, West EA, Ballouz T, Menges D, Wulf Hanson S, et al. Long COVID through a public health lens: an umbrella review. Public Health Rev. (2022) 43:1&#x2013;10. 10.3389/phrs.2022.1604501</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/phrs.2022.1604501</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Principi N, Azzari C, Cardinale F, Di Mauro G, Galli L, et al. Italian Intersociety consensus on management of long COVID in children. Ital J Pediatr. (2022) 48:1&#x2013;9. 10.1186/s13052-022-01233-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-022-01233-6</ArticleId><ArticleId IdType="pmc">PMC8905554</ArticleId><ArticleId IdType="pubmed">35264214</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang T, Hongliu CAI, Yu C, Zuobing C, Qiang F, Weili H, et al. 
Handbook of COVID-19 prevention and treatment. Handb Covid-19, Prev Treat (2020). 68. Available at: https://covid-19.alibabacloud.com</Citation></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes RC, Antonelli M, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Heal. (2021) 5:708&#x2013;18. 10.1016/S2352-4642(21)00198-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Heal. (2021) 6:1&#x2013;12. 10.1136/bmjgh-2021-005427 Handling</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Roge I, Smane L, Kivite-Urtane A, Pucuka Z, Racko I, Klavina L, et al. Comparison of persistent symptoms after COVID-19 and other non-SARS-CoV-2 infections in children. Front Pediatr. (2021) 9:1&#x2013;13. 10.3389/fped.2021.752385</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.752385</ArticleId><ArticleId IdType="pmc">PMC8586002</ArticleId><ArticleId IdType="pubmed">34778143</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, et al. Risk factors for long COVID in previously hospitalised children using the ISARIC global follow-up protocol: a prospective cohort study. Eur Respir J. (2022) 59(2):1&#x2013;21. 10.1183/13993003.01341-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, et al. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company &#x2018; s public news and information. 2020;(January).</Citation></Reference><Reference><Citation>Orsini A, Corsi M, Pedrinelli V, Santangelo A, Bertelloni C, Oste VD. Post-traumatic stress, anxiety, and depressive symptoms in caregivers of children tested for COVID-19 in the acute phase of the Italian outbreak. Hangzhou: Prof. Tingbo LIANG (2020; January). 10.1016/j.jpsychires.2021.01.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.01.024</ArticleId><ArticleId IdType="pmc">PMC7825987</ArticleId><ArticleId IdType="pubmed">33508545</ArticleId></ArticleIdList></Reference><Reference><Citation>Against G, Study C-PC. Post COVID-19 global health strategies: the need for an interdisciplinary approach. 2020; (0123456789).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7287410</ArticleId><ArticleId IdType="pubmed">32529595</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Q, Li J, Hu X, Bai Y, Zheng Y, Gao Z. Follow- ups on persistent symptoms and pulmonary function among post-acute COVID-19 patients: a systematic review and meta-analysis. Front Med. (2021) 8:1&#x2013;11. 10.3389/fmed.2021.702635</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.702635</ArticleId><ArticleId IdType="pmc">PMC8448290</ArticleId><ArticleId IdType="pubmed">34540862</ArticleId></ArticleIdList></Reference><Reference><Citation>Alarc&#xf3;n-rodr&#xed;guez J, Fern&#xe1;ndez-velilla M, Ure A. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company &#x2018; s public news and information. 2020; (January).</Citation></Reference><Reference><Citation>Magnusson K, Skyrud KD, Suren P, Greve-Isdahl M, St&#xf8;rdal K, Kristoffersen DT, et al. Healthcare use in 700 000 children and adolescents for six months after COVID-19: before and after register based cohort study. Br Med J. (2022) 376:1&#x2013;11. 10.1136/bmj-2021-066809</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-066809</ArticleId><ArticleId IdType="pmc">PMC8762452</ArticleId><ArticleId IdType="pubmed">35039315</ArticleId></ArticleIdList></Reference><Reference><Citation>Peramo-&#xe1;lvarez FP, L&#xf3;pez-z&#xfa; M&#xc1;, L&#xf3;pez-ruz &#xc1;. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- research that is available on the COVID-19 resource centre - including this. 2020; (January).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>